ScinoPharm Taiwan (Taiwan) Market Value
| 1789 Stock | TWD 23.50 0.25 1.05% |
| Symbol | ScinoPharm |
ScinoPharm Taiwan 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ScinoPharm Taiwan's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ScinoPharm Taiwan.
| 09/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in ScinoPharm Taiwan on September 28, 2024 and sell it all today you would earn a total of 0.00 from holding ScinoPharm Taiwan or generate 0.0% return on investment in ScinoPharm Taiwan over 60 days. ScinoPharm Taiwan is related to or competes with Sinphar Pharmaceutical, Grape King, Apex Biotechnology, Leatec Fine, Information Technology, Kinko Optical, and E Lead. ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells CGMP active pharma... More
ScinoPharm Taiwan Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ScinoPharm Taiwan's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ScinoPharm Taiwan upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 5.93 | |||
| Value At Risk | (1.76) | |||
| Potential Upside | 1.24 |
ScinoPharm Taiwan Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ScinoPharm Taiwan's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ScinoPharm Taiwan's standard deviation. In reality, there are many statistical measures that can use ScinoPharm Taiwan historical prices to predict the future ScinoPharm Taiwan's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (4.99) |
ScinoPharm Taiwan Backtested Returns
ScinoPharm Taiwan owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13% return per unit of risk over the last 3 months. ScinoPharm Taiwan exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate ScinoPharm Taiwan's Variance of 1.09, coefficient of variation of (980.89), and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide. The entity has a beta of 0.0233, which indicates not very significant fluctuations relative to the market. As returns on the market increase, ScinoPharm Taiwan's returns are expected to increase less than the market. However, during the bear market, the loss of holding ScinoPharm Taiwan is expected to be smaller as well. At this point, ScinoPharm Taiwan has a negative expected return of -0.13%. Please make sure to validate ScinoPharm Taiwan's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if ScinoPharm Taiwan performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.75 |
Good predictability
ScinoPharm Taiwan has good predictability. Overlapping area represents the amount of predictability between ScinoPharm Taiwan time series from 28th of September 2024 to 28th of October 2024 and 28th of October 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ScinoPharm Taiwan price movement. The serial correlation of 0.75 indicates that around 75.0% of current ScinoPharm Taiwan price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
ScinoPharm Taiwan lagged returns against current returns
Autocorrelation, which is ScinoPharm Taiwan stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ScinoPharm Taiwan's stock expected returns. We can calculate the autocorrelation of ScinoPharm Taiwan returns to help us make a trade decision. For example, suppose you find that ScinoPharm Taiwan has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ScinoPharm Taiwan regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ScinoPharm Taiwan stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ScinoPharm Taiwan stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ScinoPharm Taiwan stock over time.
Current vs Lagged Prices |
| Timeline |
ScinoPharm Taiwan Lagged Returns
When evaluating ScinoPharm Taiwan's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ScinoPharm Taiwan stock have on its future price. ScinoPharm Taiwan autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ScinoPharm Taiwan autocorrelation shows the relationship between ScinoPharm Taiwan stock current value and its past values and can show if there is a momentum factor associated with investing in ScinoPharm Taiwan.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for ScinoPharm Stock Analysis
When running ScinoPharm Taiwan's price analysis, check to measure ScinoPharm Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScinoPharm Taiwan is operating at the current time. Most of ScinoPharm Taiwan's value examination focuses on studying past and present price action to predict the probability of ScinoPharm Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScinoPharm Taiwan's price. Additionally, you may evaluate how the addition of ScinoPharm Taiwan to your portfolios can decrease your overall portfolio volatility.